T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMX
376
DELISTED
Terminix Global Holdings, Inc.
TMX
| $305M | 0.04% |
7,508,905
-5,778,567
| -43% | -$251M |
|
377
DexCom
DXCM
$34.3B
| $305M | 0.04% |
4,093,538
+194,274
| +5% | +$17.7M |
|
378
Idacorp
IDA
$8.21B
| $302M | 0.04% |
2,854,629
-90,694
| -3% | -$9.8M |
|
379
General Motors
GM
$76.1B
| $300M | 0.04% |
9,456,923
+6,290,657
| +199% | +$236M |
|
380
Pinnacle Financial Partners Inc
PNFP
$16.1B
| $300M | 0.04% |
4,151,635
+12,411
| +0.3% | +$979K |
|
381
Idexx Laboratories
IDXX
$45B
| $299M | 0.04% |
851,550
-217,711
| -20% | -$88.8M |
|
382
Charter Communications
CHTR
$17.9B
| $297M | 0.04% |
634,919
-1,620,476
| -72% | -$790M |
|
383
Caterpillar
CAT
$393B
| $295M | 0.04% |
1,652,783
-1,553,386
| -48% | -$327M |
|
384
FMC
FMC
$1.28B
| $289M | 0.04% |
2,698,917
-215,430
| -7% | -$26.3M |
|
385
Camden Property Trust
CPT
$10.9B
| $287M | 0.04% |
2,131,129
+40,037
| +2% | +$5.93M |
|
386
Bankunited
BKU
$3.38B
| $286M | 0.04% |
8,051,922
-262,431
| -3% | -$10.4M |
|
|
BPMC
387
DELISTED
Blueprint Medicines
BPMC
| $284M | 0.04% |
5,631,687
+698,562
| +14% | +$40.9M |
|
388
Webster Financial
WBS
$12.8B
| $284M | 0.04% |
6,743,470
+383,804
| +6% | +$18.5M |
|
389
Essex Property Trust
ESS
$18.1B
| $284M | 0.04% |
1,086,701
-31,421
| -3% | -$9.51M |
|
390
CNA Financial
CNA
$13.7B
| $280M | 0.04% |
6,226,654
-257,385
| -4% | -$11.8M |
|
391
Exelixis
EXEL
$12.5B
| $280M | 0.04% |
13,425,015
-2,348,770
| -15% | -$48.4M |
|
392
Vodafone
VOD
$37.2B
| $277M | 0.04% |
17,805,251
+922,429
| +5% | +$14.7M |
|
|
CCC
393
CCC Intelligent Solutions
CCC
$4.11B
| $277M | 0.04% |
30,087,903
+13,003,752
| +76% | +$119M |
|
394
Waters Corp
WAT
$40.9B
| $276M | 0.03% |
835,336
+10,114
| +1% | +$3.21M |
|
|
THS
395
DELISTED
Treehouse Foods
THS
| $276M | 0.03% |
6,591,162
-1,276,528
| -16% | -$46.9M |
|
396
BioNTech
BNTX
$23.3B
| $276M | 0.03% |
1,847,935
+321,110
| +21% | +$49.1M |
|
397
Pinterest
PINS
$13B
| $275M | 0.03% |
15,149,357
-4,927,761
| -25% | -$103M |
|
398
Reynolds Consumer Products
REYN
$5.53B
| $274M | 0.03% |
10,040,368
+236,096
| +2% | +$6.62M |
|
399
Alexandria Real Estate Equities
ARE
$8.27B
| $270M | 0.03% |
1,860,109
-110,181
| -6% | -$18.7M |
|
400
Chesapeake Utilities
CPK
$3.25B
| $269M | 0.03% |
2,076,251
-134,593
| -6% | -$17.6M |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.